NCT01869764View on ClinicalTrials.gov

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituMale Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer
Interventions
DRUG

omega-3 fatty acid

Given PO

OTHER

placebo

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

27157

Comprehensive Cancer Center of Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT01869764 - Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | Biotech Hunter | Biotech Hunter